American Journal of Cardiology
Volume 101, Issue 12 , Pages 1689-1693, 15 June 2008

Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction

  • Zongliang Lu, MD, PhD

      Affiliations

    • Fuwai Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, Peoples Republic of China
    • ,
  • Wenrong Kou, MD

      Affiliations

    • Fuwai Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, Peoples Republic of China
    • ,
  • Baomin Du, MD

      Affiliations

    • WBL Peking University Biotech Co. Ltd, Beijing, Peoples Republic of China
    • ,
  • Yangfeng Wu, MD

      Affiliations

    • Peking University Health Science Center, Peoples Republic of China
    • ,
  • Shuiping Zhao, MD, PhD

      Affiliations

    • The Second Xianya Hospital of Central South University, Peoples Republic of China
    • ,
  • Osvaldo A. Brusco, MD

      Affiliations

    • Texas A&M School of Medicine, Corpus Christi, Texas
    • ,
  • John M. Morgan, MD

      Affiliations

    • Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
    • ,
  • David M. Capuzzi, MD, PhD

      Affiliations

    • Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
    • Corresponding Author InformationCorresponding author: Tel: 610-645-8426; Fax: 610-645-2205.
    • ,
  • Chinese Coronary Secondary Prevention Study Group

Received 8 June 2007; received in revised form 18 February 2008; accepted 18 February 2008. published online 14 April 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Members of the Chinese Coronary Secondary Prevention Study Group are listed in the Appendix.

 This study was supported by the Chinese National Scientific and Technological Projects, Peoples Republic of China, and sponsored by WPL Peking University Biotech Co. Ltd (WPU), Beijing, Peoples Republic of China.

PII: S0002-9149(08)00353-6

doi:10.1016/j.amjcard.2008.02.056

American Journal of Cardiology
Volume 101, Issue 12 , Pages 1689-1693, 15 June 2008

Article Tools

* Image Usage & Resolution